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Abstract
A key component in the body’s stress response, the hypothalamic-pituitary-adrenal (HPA) axis orchestrates changes across a
broad range of major biological systems. Its dysfunction has been associated with numerous chronic diseases including Gulf
War Illness (GWI) and chronic fatigue syndrome (CFS). Though tightly coupled with other components of endocrine and
immune function, few models of HPA function account for these interactions. Here we extend conventional models of HPA
function by including feed-forward and feedback interaction with sex hormone regulation and immune response. We use
this multi-axis model to explore the role of homeostatic regulation in perpetuating chronic conditions, specifically GWI and
CFS. An important obstacle in building these models across regulatory systems remains the scarcity of detailed human in
vivo kinetic data as its collection can present significant health risks to subjects. We circumvented this using a discrete logic
representation based solely on literature of physiological and biochemical connectivity to provide a qualitative description
of system behavior. This connectivity model linked molecular variables across the HPA axis, hypothalamic-pituitary-gonadal
(HPG) axis in men and women, as well as a simple immune network. Inclusion of these interactions produced multiple
alternate homeostatic states and sexually dimorphic responses. Experimental data for endocrine-immune markers measured
in male GWI subjects showed the greatest alignment with predictions of a naturally occurring alternate steady state
presenting with hypercortisolism, low testosterone and a shift towards a Th1 immune response. In female CFS subjects,
expression of these markers aligned with an alternate homeostatic state displaying hypocortisolism, high estradiol, and a
shift towards an anti-inflammatory Th2 activation. These results support a role for homeostatic drive in perpetuating
dysfunctional cortisol levels through persistent interaction with the immune system and HPG axis. Though coarse, these
models may nonetheless support the design of robust treatments that might exploit these regulatory regimes.
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Introduction
The hypothalamic-pituitary-adrenal (HPA) axis, a key compo-
nent in the body’s stress response, serves to articulate changes in a
broad range of homeostatic regulators as a function of environ-
mental cues. Such cues can consist of both physical stressors
(injury, infection, thermal exposure) and psycho-emotional stress-
ors (frustration, fear, fight or flight decisions). Instantiation of this
survival program is accomplished through controlled modulation
of the neuroendocrine and immune systems, as well as the
sympathetic nervous systems [1–3]. Considering its function as a
broad-reaching integrator of major physiological systems, it is no
surprise that numerous chronic conditions have been associated
with abnormal regulation of the HPA axis, including major
depressive disorder (MDD) [4,5], post-traumatic stress disorder
(PTSD) [6–8], Alzheimer’s disease [9], Gulf War Illness (GWI)
[10–12], and chronic fatigue syndrome (CFS) [13–15]. When
compared to non-deployed veterans, Golier et al. [10] found that
symptomatic Gulf War veterans without psychiatric illness, as well
as veterans with PTSD alone, showed significantly greater cortisol
suppression to dexamethasone (DEX) suggesting markedly en-
hanced negative feedback along the HPA axis. Further study by
these same investigators indicated that this might be due to a
significantly attenuated ACTH response by the pituitary in
veterans with GWI without PTSD [11,12]. A similar suppression
of cortisol response to DEX was found in CFS subjects by Van
Den Eede et al. [13] with this being further exacerbated by
oestrogen intake. With regard to HPA circadian dynamics, CFS
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subjects were found to exhibit significantly increased adrenal
sensitivity to ACTH and marginally increased inhibitory feedback
during the nocturnal period when compared with control subjects
and CFS subjects comorbid with fibromyalgia (FM) [14,15].
Conversely the pain-dominant CFS-FM subjects showed signifi-
cantly blunted cortisol inhibitory feedback. While evidence such as
this implicates abnormal regulation of HPA function leading to
chronic hypocortisolic and hypercortisolic states in these illnesses,
the genesis of this dysregulation is unclear.
Previously we investigated the possibility that some of these
pathological states may coincide with naturally occurring alternate
homeostatic stable states [16]. These ‘‘backup programs’’ would
offer a way of maintaining homeostatic control in crisis situations
at the cost of reduced function. The existence of such multiple
stable states is characteristic of systems that incorporate feed-
forward and feedback mechanisms. Feed-forward loops in biology
play the crucial role of driving rapid acute responses, while
feedback loops will generally limit the extent of a response. Both
will also drive complex dynamic behavior, including differentiation
and periodicity [17]. While small perturbations may force
temporary departures, these systems return to their original
resting states once these perturbations are removed. If however,
the perturbation is of significant strength and duration, the system
may be incapable of returning to its normal operating regime and
instead may assume a new alternate resting state. Knowledge of
the system dynamics can allow us to map these different stable
states and several mathematical models of the HPA exist [16,18–
22]. So far, only one such model is known to accommodate multi-
stability in the dynamic behavior of the HPA axis. It does so via
the addition of a feed-forward mechanism involving dimerization
of the glucocorticoid receptor (GR) complex [22] (Figure 1). In this
process glucocorticoid (GC) bound GRs form homodimers that
translocate into the cell nucleus to bind DNA, up-regulating GR
synthesis and producing a positive feedback loop. However, this
model and the majority of other models do not extend beyond the
physiological boundaries of the HPA axis itself and thus are limited
in their predictive capabilities. As discussed in the following
sections, HPA activity is intertwined with the behavior of the
hypothalamic-pituitary-gonadal (HPG) axis and the immune
system, among others, and this interplay should not be ignored
when considering the number and nature of stationary states
available to the overarching system. Our hypothesis is that these
alternate regulatory regimes may facilitate the persistence of
complex chronic illnesses like GWI and CFS. To evaluate the role
of alternate homeostatic attractors in these illnesses we constructed
a computational model of regulatory control linking the HPA,
HPG and immune systems.
There is a substantial body of physiological and biochemical
data for many biological systems describing the connectivity
between molecular and cellular elements, the presence of recurring
structural motifs and functional modules. For example, negative
autoregulation, in which a transcription factor represses its own
transcription, is a simple network motif observed in many
transcription networks. While, numerous motifs have been found
in biological networks (negative/positive autoregulation, coher-
ent/incoherent and multi-output feed-forward loops, single-input
modules and dense overlapping regulons) [17], data regarding the
precise stoichiometry and kinetics within and between these
multiple systems in humans is extremely limited. Obtaining many
of these parameters in humans currently presents significant
challenges associated with invasive sampling. As such, many
existing models rely heavily on animal data as a source of kinetic
parameters, or adopt general order of magnitude estimates when
this data is unavailable. Using such estimates allows Ordinary
Differential Equation (ODE) based models to provide detailed
descriptions of transitory behavior, albeit for well-characterized
systems. To broaden this scope and draw on the rich body of
known molecular and cellular interactions in physiological and
biochemistry, we have adopted the discrete logical network
methodology proposed originally by Thomas et al. [23,24] and
developed further by Mendoza and Xenarios [25]. By applying
logic rules to a network of known interactions it is possible to
identify the number of stable resting states, their type as well as
their molecular and cellular description, without detailed knowl-
edge of the response dynamics. Here detailed kinetic data is not
required as working with connectivity alone allows useful
qualitative insights regarding the stability of these systems. In this
work we use this method to extend our previous analysis of human
HPA axis dynamics by including its regulatory interactions with
the neighboring HPG axis and immune system. This resulting
mathematical model better represents the complexity of endo-
crine-immune interactions by supporting the detection and
identification of alternate resting modes of the HPA-HPG-immune
axis. Based on connectivity information alone, we show that multi-
stability is easily obtained from these interacting systems.
Moreover, we show that experimental data from our on-going
studies of GWI and CFS show better alignment with these
alternate resting modes than with the typical healthy homeostatic
stable state. Ultimately, knowledge of such homeostatic modes
could be used to identify promising applications of pharmaceu-
tical, hormone and/or immune therapy that exploit the body’s
natural dynamics to reinforce treatment effects.
Methods
Ethics Statement
All subjects signed an informed consent approved by the
Institutional Review Board of the University of Miami. Ethics
review and approval for data analysis was also obtained by the
IRB of the University of Alberta.
An Integrative Multi-systems Model of the HPA-HPG-
Immune System
There is a substantial amount of physiological data describing
the HPA, HPG and immune systems as stand-alone entities. To a
much lesser degree there also exists evidence for the mutual
interactions between these systems. The following sections describe
the experimental evidence used to infer the topology of an
overarching HPA-HPG-immune interaction network (Figure 1).
The HPA Axis. Activation of the HPA axis begins at the
paraventricular nucleus (PVN) of the hypothalamus. Specifically,
afferents transmitting stress related information in the brain
converge on the medial parvocellular neurons of the PVN
inducing the release of several peptides, including corticotropin-
releasing hormone (CRH) and arginine vasopressin (AVP), into
the pituitary hypophysial-portal circulation. The unique vascular
system allows very small quantities of these hypothalamic
hormones to act directly on their targets in the anterior pituitary
without dilution by systemic circulation. CRH and AVP act in
conjunction on membrane bound CRH-R1 receptors in the
anterior pituitary to stimulate adrenocorticotropic hormone
(ACTH) synthesis, and its rapid release into peripheral circulation.
ACTH circulates to the adrenal cortex where it acts on the
membrane bound MC2-R receptor to simulate the release of GCs
(corticosterone in the rat, and cortisol (CORT) in humans and
nonhuman primates). To regulate the stress response, GCs exert
negative feedback at the hypothalamus and pituitary to inhibit
further synthesis and release of CRH and ACTH, respectively
Homeostatic Drive and Complex Chronic Illness
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[26]. This is the standard view of the HPA axis utilized in the
majority of models (Figure 1 A). However, as noted by Gupta et al.
[22] circulating glucocorticoids act via cytostolic GRs, which,
unlike membrane bound receptors, dimerize (GRD) and translo-
cate into the cell nucleus upon activation to up-regulate GR
synthesis and interact with other relevant transcription factors, or
GC-sensitive genes (Figure 1 B). Gupta et al. included this GR
expression feed-forward loop at the pituitary, as it is a main driver
of the HPA axis, and found a resulting bistability in the HPA
system [22]. However, all nucleated cells possess GRs, as GCs
influence practically every system in the body, suggesting this feed-
forward loop may be important in other tissues beyond the HPA
axis. As described below major systems affected by GCs include
the HPG axis and the immune system.
The HPG Axis. GCs have an inhibitory effect on the HPG
axis, a central regulator of the reproductive system, at all levels
[27–31]. Activation of the HPG starts from brain generated
pulsatile signals that stimulate the preoptic area of the hypothal-
amus to produce gonadotropin-releasing hormone (GnRH).
GnRH is secreted into the pituitary hypophysial portal blood-
stream, which carries it to the pituitary gland, where it activates
membrane bound GnRH-R receptors, resulting in the synthesis
and secretion of luteinizing hormone (LH) and follicle-stimulating
hormone (FSH) into circulation. These gonadotropins flow to the
gonads where they work synergistically to promote the secretion of
the sex steroids. In males, LH binds to receptors on Leydig cells in
the testes to stimulate the synthesis and secretion of testosterone
(TEST). In females, LH activates receptors on Theca interna cells
in the ovaries to stimulate the release of androstenedione, which is
aromatized by granulosa cells to produce estradiol (EST), and
progesterone (PROG). TEST negatively feeds back on the HPG to
inhibit GnRH, FSH and LH secretion and synthesis [27]. This
Figure 1. Standard and extended HPA models. (A) Standard HPA model. (B) HPA-GR model of Gupta et al. [22]. Integrated models (C) HPA-
GR-Immune-HPGa for males, and (D) HPA-GR-Immune-HPGb, (E) HPA-GR-Immune-HPGc, (F) HPA-GR-Immune-HPGd, and (G) HPA-GR-Immune-HPGe
for females. For (C) – (G) connections between the sex steroid EST and the HPG and HPA components change between stimulatory and inhibitory to
capture the effects of the menstrual cycle.
doi:10.1371/journal.pone.0084839.g001
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feedback mechanism is somewhat more complex in females where,
depending on the phase of the female menstrual cycle, EST and
PROG can exert either positive or negative feedback on the
production and release of GnRH and the gonadotropins
[30,32,33].
A lesser-known aspect is that several components of the HPG
axis exert reciprocal effects on the HPA axis [27,28,30].
Testosterone exhibits an inhibitory effect on all levels of the
HPA [27] (Figure 1 C), whereas EST and PROG can serve to
stimulate or inhibit the HPA axis depending on menstrual cycle
phase, or phase of life [28]. These affects may be mediated
through changes in adrenocorticoid synthesis, stress-induced
ACTH and GC release, and CRH and AVP synthesis in the
PVN, by direct activation of oestrogen and androgen receptors
along the HPA or via interaction between GRs and sex steroid
receptors to regulate transcription [27,28,30]. Thus, an interactive
functional crosstalk exists between the HPA and HPG axes, which
cannot be ignored when investigating HPA axis regulation and
dysfunction. Mutual inhibition between the HPA and HPG
(Figure 1 C) was considered standard for males. However, as it is
not clear whether the EST and PROG inhibition/stimulation of
the HPA occurs in coordination with the inhibition/stimulation of
the HPG, these cases were explored for females alone as separate
alternative models of the HPA-HPG interaction (Figure 1 D–G) in
addition to the model considered for males.
A Simple Model of the Immune System. While not
typically considered part of the neuroendocrine system, the
immune system plays a very important role in regulating the
HPA axis. Here we base our simplified immune system upon our
previous work detailing the communication network of the
immune response [34]. Cells of the innate immune response
(ICells), including mononuclear phagocytes, such as macrophages,
and dendritic cells, natural-killer (NK) cells, endothelial cells and
mucosal epithelial cells, communicate via the release of numerous
cytokines. Cytokines that regulate the innate immune response
(IIR) include interleukin (IL) -1, IL-6, IL-8 and tumor necrosis
factor alpha (TNF-a), and can also include IL-12, a primary
mediator of early innate immunity. Primarily, these signals serve to
activate and recruit other ICells, which in turn produce more
cytokines. IL-15, which stimulates proliferation of NK cells and
effector T-lymphocytes, can also be considered as part of the IIR
as well as IL-23, an important inflammatory signal contributing to
the Th17 response against infection.
IIR signals can also serve to prime helper T cells towards a Th1
type adaptive immune response (T1Cell). This response produces
Th1 proinflammatory cytokines (T1Cyt) including IL-2, interfer-
on-gamma (IFN-c), and tumor necrosis factor beta (TNF-b), which
further activate ICells, while suppressing the Th2 adaptive
immune response (T2Cell). The T2Cell is responsible for the
production of the Th2 anti-inflammatory cytokines (T2Cyt) IL-4,
IL-5, IL-10 and IL-13, which have important anti-inflammatory
and immunosuppressive activities, and serve to inhibit the activity
of T1Cell and ICells.
Cytokines can also serve as mediators between the immune and
endocrine systems. Between the HPA and the immune network
there exists a mutual crosstalk [35–37] (Figure 1 C–G). The IIR
and T1Cell cytokines selected here serve to stimulate the HPA axis
at all levels [35–37]. CORT, in turn, acts to suppress the activity of
ICells (specifically NK cells [38], and DC cells [39]), and the
T1Cell [40] causing a shift from the inflammatory to the anti-
inflammatory response [35,36,41]. The interaction between the
HPG and the immune system is complex and sexually dimorphic,
and is still an active field of research. However, at a general coarse
level of description TEST serves to stimulate the development of
the Th1 response [42] (Figure 1 C), whereas EST inhibits the Th1
response causing a shift towards the Th2 anti-inflammatory
response [42,43]. The reciprocal crosstalk from the immune
system to the HPG is equally intricate. In broad terms this
conversation is communicated via T1Cyt. Receptors for TNF-a
and IFN-c are expressed in testicular Leydig cells and there is
evidence that these cytokines can directly inhibit testosterone
production [44]. TNFa also decreases the release of GnRH in the
hypothalamus and LH in the pituitary gland in both males [44]
and females [45] eventually leading to a decrease in sex steroid
levels. As such, we model the T1Cyt as inhibiting GnRH and LH/
FSH in both male and female models.
A Discrete State Representation
Following the methods of Thomas et al. [23,24], and more
recently Mendoza and Xenarios [25], the neuroendocrine-
immune system was represented as a connectivity model consisting
of interconnected molecular and cellular variables with three
discrete states: 21 (inhibited), 0 (nominal) and 1 (activated).
According to this type of model the current state of all variables in
a system is described by a state vector ~x(t), such that:
~x(t)~(x1(t),x2(t), . . . ,xN (t)) ð1Þ
where xi(t) is the state of the i
th variable of the N variable system at
time t. The image vector ~x(tz1) describes the preferred state
towards which the system evolves in the next time increment. The
state value of the image vector for the ith variable is determined
from its current state and a set of balanced ternary logic statements
based on the current value of variable and the mode of action (i.e.
activate or inhibit) of the neighboring input variables. These logic
statements are expressed as follows (Eq. 2):
xi(tz1)~
(xAi1(t) _ xAi2(t) _ _xAij (t))+(xIi1(t) _ xIi2(t) _ _xIik(t))
(xAi1(t) _ xAi2(t) _ _xAij (t))
:(xIi1(t) _ xIi2(t) _ _xIik(t))
8><
>: ð2Þ
where the =, ~, and symbols are ternary HIGH/LOW PASS,
OR and NOT operators, xAij is the state of the i
th variable’s jth
activator, xIikis the state of the i
th variable’s kth inhibitor. The
ternary operators given in Equation (2) are described in further
detail in Table 1, Table 2, Table 3. The first entry in Equation (2)
is used when the variable possesses activators and inhibitors, the
middle when the variable has only activators and last when the
activator has only inhibitors.
Applying Equation (2) to each variable in the model for the mth
state of the system, ~xm(t), defines the image vector ~xm(tz1) for
that state. With ~xm(tz1) defined, the system may be updated
asynchronously (allowing only one variable to change at a time)
following the generalized logical analysis of Thomas et al. [23,24].
According to this method the ith variable of the mth state vector
Table 1. Ternary HIGH/LOW PASS operator.
A =B B = 21 B = 0 B = 1
A = 21 0 0 21
A = 0 0 0 21
A = 1 1 1 0
doi:10.1371/journal.pone.0084839.t001
( )
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xmi (t) is moved one step towards its preferred image x
m
i (tz1) (e.g.
If xmi (t) = 21 and x
m
i (tz1) = 1, then x
m
i (tz1) is set to 0). Thus,
for each current state of the system there are potentially several
subsequent states towards which it may asynchronously evolve.
The number of states, and the values they can be assigned,
determine the total number of states available to the model system.
With the ternary logic used here, a model of N variables possesses
3N states. As a result, the number of states increases rapidly as new
variables are added. By analyzing all possible states of the system a
temporal sequence of states may be discerned. To interpret the
results, each state of the system can be represented as an element
in a graph. The evolution from one state to a subsequent state can
be represented as a directed edge between the two states in this
graph. Representation of the state trajectories in this fashion
makes it possible to draw on the concepts and tools of graph theory
for analysis of the system dynamics. Steady states are defined as
those states for which the image vector is the same as the current
state vector; in other words the state possesses an out degree of 0.
Experimental Data
Experimental data obtained as part of a larger on-going study
investigating changes in cytokines and hormones in GWI and CFS
groups was used as a basis for comparison with the predicted
resting states. Previous work with the CFS datasets by Broderick et
al. presents full repeatability statistics on the cytokine panels using
n = 9 CFS, and n = 12 controls [46]. Significant changes in
correlation patterns linking immune gene sets in CFS with n = 39
CFS and n = 35 controls) [47]. Similarly in GWI we observed
significant changes in association patterns (mutual information) for
n = 9 GWI and n = 11 controls across 3 points in time [48] for
salivary cortisol and plasma, serum or culture supernatants
expression of neuropeptide Y (NPY), IL-1a, IL-5, IL-6, IL-10,
TNF-a, IFN-c and soluble CD26 (sCD26). Larger sample sizes are
used in this work to further improve the statistical power and
resolution in identifying characteristic differences between subject
groups.
GWI. Cytokine profiles and endocrine measures were ob-
tained for 27 GWI and 29 HC subjects recruited from the Miami
Veterans Administration Medical Center. Subjects were male with
an average age of 43 years and BMI of 28. Inclusion criteria was
derived from Fukuda et al. [49], and consisted in identifying
veterans deployed to the theater of operations between August 8,
1990 and July 31, 1991, with one or more symptoms present after
6 months from at least 2 of the following: fatigue; mood and
cognitive complaints; and musculoskeletal complaints. Subjects
were in good health prior to 1990, and had no current
exclusionary diagnoses [50]. Collins et al. [51] supports the use
of the Fukuda definition in GWI. Control subjects consisted of gulf
war era sedentary veterans and were matched to GWI subjects by
age, body mass index (BMI) and ethnicity. Additional details
regarding this cohort and the laboratory assays performed are
available in Broderick et al. [48]. Data will be made freely
available upon request.
CFS. Levels of cortisol (CORT) and estradiol (EST) measured
in peripheral blood were obtained from the Wichita Clinical
dataset [52] for a group of 39 female CFS subjects and 37 Healthy
controls (HCs) with an average age of 52 years and an average
body mass index (BMI) of 29. Additional details of this cohort and
the laboratory assays performed may be found in work previously
reported by our group [53,54]. Multiplex cytokine profiles were
obtained in plasma from a separate but demographically
comparable cohort of 40 female CFS subjects and a group of 59
healthy female matched control subjects studied by our group at
the University of Miami [55]. Average age in this cohort was 53
years with an average BMI of 26. Profiling of cytokine
concentrations was performed in morning blood plasma samples
using an enzyme-linked immuno-absorbent assay (ELISA)-based
assay. Details of this protocol and results of a comparative analysis
of cytokine expression patterns are available in Broderick et al.
[55]. In both studies a diagnosis of CFS was made using the
International Case Definition [50,56]. Exclusion criteria for CFS
included all of those listed in the current Centers for Disease
Control (CDC) CFS case definition, as well as psychiatric
exclusions, as clarified in the International CFS Working Group
[56]. Data will be made freely available upon request.
Statistical Analysis
Brown’s theoretical approximation [57] of Fisher’s statistics was
used to calculate the significance of alignment between experi-
mental data and a given model predicted state. Fisher’s method, a
meta-analysis technique, combines probabilities to obtain the
overall significance P of a set of p-values obtained from






where N is the number of measureable variables and pi is the
corresponding p-values under the null hypothesis, has a x2
distribution with 2N degrees of freedom assuming that the
performed tests are independent. As the molecular variables of
the endocrine and immune system interact with one another, as
evidenced by the above connectivity diagrams, they are not
independent. As a result, direct application of this test statistic is
invalid, since the assumption of independence is violated. Brown
[57] suggested a method for combining non-independent tests. If
the tests are not independent, then the statistic T0 has mean







where pi and pj are the p-values for each test and the covariance
(cov) is calculated as,
Table 2. Ternary OR operator.
A~B B = 21 B = 0 B = 1
A = 21 21 0 1
A = 0 0 0 1
A = 1 1 1 1
doi:10.1371/journal.pone.0084839.t002
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with rij being the unadulterated correlation between variable i and
variable j. Finally, the overall significance P of a set of non-
independent tests is calculated using the statistic T which under the
null hypothesis follows the central x2 distribution, where T = T0/c
with 2N/c degrees of freedom and c = s2/4N.
Here, we test if each experimental measure aligns with a given
model predicted state. Our null hypothesis is that the experimental
measures do not align. p-values for individual variables, pi, are
calculated using two-sample t-tests between ill subjects and healthy
controls. Where model predictions give a variable as high (+1),
‘right-handed’ one-tailed test are used, whereas a ‘left-handed’ test
was used when model predictions are low (21), to give the
probability of obtaining the predicted value when the null
hypothesis is true. For the case where the model predicts normal
behavior for a variable (0) a two-tailed t-test is used. However, the
p-value from the two-tailed test, ptwo-tail, gives the probability that
there is an observable difference between illness and control,
which is the null hypothesis. To rectify this, when comparing to a
model predicted variable of 0 we take the p-value to be pi = 1 2
ptwo-tail, giving the probability of obtaining the predicted value
when the null hypothesis is true.
All cohort data was normalized using a Log2 transformation
before T-tests and correlation calculations were performed. The
unadulterated correlation values rij between two variables i and j
were calculated in healthy subjects as the pairwise Pearson’s linear
correlation coefficient between variables. The above-mentioned
experimental data was compared against model predictions based
on the five measureable variables, namely TEST/EST, CORT,
IIR, T1Cyt, and T2Cyt. Where model variables represent an
aggregate set of markers each experimentally measured constitu-
ent marker was compared individually to the model predicted
value. For example, T1Cyt is composed of IL-2, IFNc and TNFb,
therefore 3 individual p-values were calculated based on the
predicted value of T1Cyt.
These significances of alignment are best visualized with a
Sammon projection of the aggregated P value as distances between
the clinical data and the predicted model values. Non-metric
multidimensional scaling using Sammon’s nonlinear mapping
criterion was used to project the P value distances onto a 2
dimensional plot. The aggregate P values between predicted
model states were determined via Brown’s method above. Where
values between predicted states were found to disagree p-values for
individual variables, pi, were taken as 1. Where values between
predicted states were found to agree, pi was assigned a standard
minimum value for significance of 0.05 to avoid numerical
instability in the calculation of T0.
Results
Stable States in the HPA Models
Application of the discrete state representation to the basic
stand-alone HPA model (Figure 1 A) generated 27 system states,
and failed to produce multiple stable resting states (Figure 2). The
only stable state found consisted of baseline values (SS0) for all
state variables. This result is consistent with previous ordinary
differential equation models based on this minimal representation
of the HPA axis that produce solutions converging to a single fixed
state [18].
Discrete state representation of the HPA-GR model (Figure 1 B)
generated 243 system states. Of these, 2 system states possessed no
outbound edges and were stable attractor steady states (Figure 2).
In the first steady state all state variables assumed nominal values
(SS0) whereas the second steady state corresponded to activation
of state variables GRD and GR with suppression of ACTH and
CORT (SS1). This hypocortisolic solution is consistent with that
obtained by analysis of the ordinary differential equation model of
the HPA-GR system proposed by Gupta et al. [22] and Ben Zvi et
al. [16]. Further models by Walker and colleagues, based on
Gupta et al. [22], have shown natural oscillatory rhythms in the
HPA axis [19–21]. While these models make the significant
association between delayed feedback and ultradian rhythms, the
oscillations around baseline are small and consistent, representing
a single resting behavior. As our discrete state representation
considers normal resting values as 0, with 21 and 1 representing
significant perturbations, minor deviations are not captured and
therefore such small oscillatory behavior can be considered similar
to our nominal steady state (SS0). This lower resolution allows for
a greater breadth of study, accommodating the inclusion of
multiple systems of interest, which previously have not been
considered in modeling studies.
Combining the HPA-GR axis with the HPG axis and immune
system (Figure 1 B–G) altogether produced 4,782,969 system
states. For the male HPG (model a) (Figure 1 C), and three of the
four female HPG models (models b, d and e) (Figure 1 D, E, G)
five steady states were identified (Figure 2). One stable state is
characterized by nominal values for all variables (SS0), which
corresponds to the typically normal resting state of the system. The
first alternate state (SS1) displays low ACTH with high GRD and
GR, while the second (SS2) has inhibited innate and Th1 immune
responses (low ICell, IIR, T1Cell, and T1Cyt), with increased Th2
activity (high T2Cell and T2Cyt). The third stable state (SS3)
appears to be a combination of SS1 and SS2 with low ACTH,
ICell, IIR, T1Cell and T1Cyt, and high GRD, GR, T2Cell and
T2Cyt. The final state (SS4) presents with hypercortisolism,
suppressed TEST and a shift towards the Th1 immune response
(low T2Cell, T2Cyt, GnRH, LH/FSH and TEST/EST, and high
CORT, GRD, GR, T1Cyt and T1Cell). The persistently low
CORT state seen in the previous stand-alone HPA models of
Gupta et al. [22] and Ben Zvi et al. [16] was not recovered here.
Instead, CORT was expressed at a nominal or high value for all
predicted states. SS1 most closely resembles the results of Gupta et
al. [22], and Ben Zvi et al. [16], however these previous models
only considered a single regulator of CORT, namely ACTH. The
lack of a predicted hypocortisolic state in SS1 here can be
attributed to the interplay of multiple regulators of CORT
(ACTH, IIR, TEST/EST, and T1Cyt). Inclusion of additional
regulators is not expected to further alter this state.
In the final female HPG model (model c) (Figure 1 F),
corresponding to the ovulation phase, these same five states were
recovered along with six new additional states (Figure 2). In the
first three additional states the HPA axis and innate immune
response are suppressed with low CRH, ACTH, CORT, ICell
and IIR, while the HPG and anti-inflammatory response are
raised with high T2Cell, T2Cyt, GnRH, LH/FSH and EST. The
difference between the three states is noted in the level of
glucocorticoid receptor response, GR and GRD, which together
take values of low (SS5), nominal (SS6) and high (SS7). The
remaining three additional states all give suppressed HPA (CRH,
ACTH, and CORT) and lowered T1Cell activity, with high HPG
activity (GnRH, LH/FSH and EST), and are again differentiated
by their glucocorticoid receptor levels (GR, GRD): low (SS8),
nominal (SS9) and high (SS10).
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Overall, inclusion of the simplified immune system and the
HPG works to regulate CORT levels in the HPA axis. The male
HPG (HPG model a), and the majority of female HPG
configurations (HPG models b, d and e), serve to produce either
nominal values of CORT, with the potential of a shift towards
Th2 activation (SS2 and SS3), or a hypercortisolic state with low
TEST/EST and a shift towards Th1 (SS4). Only connections
associated with the female gender (HPG model c) were responsible
for the emergence of a natural hypocortisolic state (SS5 – SS10).
This hypocortisolic state comes with high EST and may have a
shift towards Th2 activation in the immune system.
Comparison of GWI and CFS to Predicted States
Application of Brown’s meta-analysis method allowed for the
calculation of a combined P-value comparing the experimental
data with the predicted stable states, allowing for the alignment
between different predicted stable states to be ranked. As
experimental measures allowed for comparison with only five
variables (TEST/EST, CORT, IIR, T1Cyt, and T2Cyt) several of
the predicted stable states resulted in the same experimental profile
and resulting combined P-value despite being distinct states (e.g.
SS0 and SS1 both show nominal values for the five measureable
variables).
To compare to our model the difference between steroid and
cytokine levels recorded in male Gulf War veterans with GWI and
HCs were compared to the steady state values predicted by the
male variant of the HPA-GR-Immune-HPG model (model a).
Comparison to the nominal states (SS0/SS1) showed poor
alignment, PSS0/SS1 = 0.82, suggesting that the GWI profile cannot
be considered the same as nominal behavior. Alignment with
states presenting a shift towards Th2 immune activation (SS2/SS3)
showed better alignment, PSS2/SS3 = 0.38, although with low
significance. The final state, displaying hypercortisolism, low
TEST and a shift towards Th1 immune activation (SS4), yielded
the best alignment, PSS4 = 0.30, again however, with a low overall
significance. These alignments are illustrated via the Sammon plot
shown in Figure 3A.
The difference between steroid and cytokine levels of female
CFS subjects and HCs were compared to the steady state values
predicted by the female variants of the HPA-GR-Immune-HPG
models (model b-e). Again, alignment with states presenting
nominal changes in measureable variables (SS0/SS1) was poor,
PSS0/SS1 = 0.83, supporting that CFS is distinctly different from
normal behavior. The Th2 shifted immune profile states (SS2/
SS3) showed a significant alignment, PSS2/SS3 = 0.04, suggesting
Th2 activation in CFS. This is further supported by low alignment
with the Th1 immune activated state, with hypercortisolism,
and low EST (SS4), PSS4 = 0.28. Improved alignment is
seen in states with a shift towards Th2, coupled with hypocorti-
solism, and high EST (SS5/SS6/SS7), PSS5/SS6/SS7 = 0.02, sug-
gesting that these features contribute to the CFS profile. This is
also supported by low alignment with states only presenting
hypocortisolism and high EST with no immune activation (SS8/
SS9/SS10), PSS8/SS9/SS10 = 0.60. These alignments are visualized
in Figure 3B.
Discussion
The existence of multiple stable states is a prime characteristic
of systems incorporating feed-forward and feedback mechanisms,
and plays a critical part in guiding the complex dynamics observed
in biology. These alternate stable regulatory regimes occur due to
the feed-forward and feedback mechanisms within the system and
may allow escape routes for survival of an insult and provide
support in the medium or long-term to what is equivalent to an
uneasy cease-fire or adaptive compromise. Examples of such
compromises in functional status in exchange for survival include
vasovagal response to decreased blood pressure and syncope
(‘‘fainting’’) [58]. From an evolutionary perspective it would be
advantageous for a pathogen to establish an adaptive relationship
with the host. As naturally occurring alternate states of homeo-
stasis are inherently stable, exploiting these regimes could be an
advantageous way for a pathogen to establish long-term chronic
infection, in essence using the body’s own homeostatic drive to
maintain the status quo. Deviations of persistent illness profiles
from normal homeostatic states argue in favor of the continued
presence of an initial aggravating factor or of lasting alterations to
the regulatory circuitry imparted by the initial insult [59,60]. The
Figure 2. Steady states of standard and extended HPA models. White – nominal state (0); Green – high state (1); Red – low state (21); Grey –
N/A to the model.
doi:10.1371/journal.pone.0084839.g002
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latter would essentially modify the solution landscape resulting in
new natural attractors. To explore this hypothesis, we constructed
a simple but integrated model incorporating three of the body’s
major regulatory axes: the HPA, the HPG and the immune
system. Modeling the dynamic properties of these complex systems
presents a significant challenge, as much of the detailed
information describing in vivo kinetics in humans is unavailable.
However, there is a very significant body of connectivity data
describing the interactions between the molecular and cellular
elements of these biological systems. To make use of this wealth of
information we have applied a discrete state representation to the
neuroendocrine immune system based solely on the biological
connectivity found in the literature and a set of ternary logical
rules. Using a discrete logic methodology proposed by Thomas
[24], we demonstrated that the inclusion of feed-forward/feedback
loops leads to multiple stable states. Indeed, addition of the
positive feedback loop regulating glucocorticoid receptor dimer-
ization (GR-GRD) to a basic model of the HPA axis generated an
alternate homeostatic state characterized by high receptor
expression and low circulating cortisol levels, a result found
previously by Gupta et al. [22] and Ben Zvi et al. [16] using
differential equation based models. So dependent is the natural
emergence of these states on the regulatory wiring that inclusion of
this receptor dimerization in a more complex HPA-Immune-HPG
models resulted in the disappearance of this alternate hypocorti-
solic state through compensatory effects of these axes. Only when
all three interacting axes were included was an alternate
hypocortisolic condition recovered. Therefore while simple models
require the inclusion of positive receptor feedback dynamics to
produce multistability, these effects become inherent in more
coarse, but comprehensive regulatory circuits, and receptor-level
feedback becomes less of a contributor in the support of multiple
attractor states. Coarse-grained but comprehensive models may
suffice therefore in capturing physiologically relevant and clinically
verifiable response dynamics.
Our analysis of these coarse grained models spanning across
multiple regulatory axes highlighted the important role of gender
in supporting a persistent hypocortisolic condition. Due to the
suppressive actions of the male gonadal system in regulating itself
and the HPA axis, a low cortisol steady state is never available to
the male, at least theoretically at this level of detail. In women
however, the combined effect of EST and PROG on the HPA still
remains somewhat inconsistent [28,61] owing to the varying
effects of these hormones during and after the menstrual cycle.
EST is generally believed to stimulate the HPA axis during the
menstrual cycle [61-63], however evidence indicates that in
perimenopausal, menopausal or ovariectomized women the HPA
axis response is inversely correlated with plasma EST levels
suggesting an inhibitory effect [63,64]. This suggests that sex
hormone regulation may change in feedback polarity and act as
both inhibitor and activator of the HPA axis. For this reason HPA-
HPG interaction in women will in theory readily support the
presence of a stable hypocortisolic condition when HPG axis
regulation inhibits the HPA axis while stimulating itself.
In addition to sex hormone regulation, interaction with the
immune system also appears to play a significant role in
determining abnormal cortisol levels. In our coarse-grain models,
cortisol exerts a suppressive action on the innate immune system
and the Th1 adaptive immune response. Conversely, positive
feedback by certain components of the immune system promotes
increases in cortisol levels, which support a hypercortisolic steady
state. While, inclusion of the glucocorticoid receptor dimerization
(GR-GRD) in these models yielded additional steady states, it did
not result in any significant changes to the profile in regards to
cortisol levels. Combining the actions of HPA, HPG and immune
regulation supported the existence of a stable hypercortisolic state
in all models of men and women while a persistent hypocortisolic
state was available only in women and only under certain modes of
HPG regulation. Once again, while the inclusion of the GR-GRD
receptor dimerization in this overarching model yielded additional
Figure 3. Sammon projection of illness and model predicted states. Axes represent arbitrary units such that the relative Euclidean distance
between points approximates the significance of alignment P-value between states, as shown by connecting lines. (A) Male GWI. (B) Female CFS.
doi:10.1371/journal.pone.0084839.g003
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steady states, it did not result in any significant changes to the
homeostatic profiles.
These findings suggest that abnormally high levels of cortisol
and adaptive immune activation, in this case Th1, may be
perpetuated under certain conditions by the system’s own
homeostatic drive. This prediction of persistent and stable Th1
activation is consistent with evidence of anomalies in immune
signaling in GWI [48,65,66]. Skowera et al. measured intracellular
production of cytokines in peripheral blood and found ongoing
Th1-type immune activation in symptomatic Gulf War Veterans
compared to healthy counterparts [65]. More recent work
confirmed this finding while also suggesting that this may occur
in the more complex context of a mixed Th1:Th2 response [48],
something not captured by the simple immune model used here.
Though we were unable to find documented reports of lower
testosterone levels in GWI beyond the experimental data
presented here, a large study of gulf war veterans in the UK
found increased risk of fertility problems in this population [67],
suggesting a possible relation.
In much the same way, conditions involving hypocortisolism
and a Th2 shift may also be perpetuated at least in part by the
natural homeostatic regulatory programming. In this case the
homeostatic program may be driven by sex steroid suppression of
the HPA axis and promotion of HPG function coupled with the
mutual inhibition between the Th1 response and function of the
gonadal axis, a configuration seemingly available only to female
subjects in our models. This would suggest that the hypocortiso-
lism seen in diseases, such as CFS [68–70], could be a result of the
complexity afforded by the interaction between the HPA, immune
and HPG axes in female subjects. Indeed model predictions
describing such an alternate homeostatic state in women aligned
with our experimental results from CFS subjects, and is consistent
with previous findings of Th2 activation in CFS [55,71–73]. This
alignment with a naturally occurring homeostatic conditions may
explain, at least in part, the biased prevalence of such persistent
diseases in women [74–79]. Indeed, these authors report that
approximately 70% of observed CFS patients are women.
Additionally, the prevalence of CFS in the 40–49-year-old age
range [79], and the higher prevalence of gynecological conditions
and gynecological surgeries in women with CFS [80] supports the
evidence that HPA suppression by estradiol appears more likely in
perimenopausal, menopausal or ovariectomized women [63,64].
Interestingly, as many as 1 in 3 CFS subjects have reported
symptom relief during pregnancy [81]. The normal trend in
pregnancy towards increased cortisol levels, especially in the third
trimester, might be a contributing factor that would support the
key involvement of sex hormone regulation proposed by our
analysis [82]. While, in normal pregnancy this increase in cortisol
typically coincides with an increase in cortisol-binding globulin
(CBG) maintaining the level of free cortisol, CBG genetic variants
in CFS have the potential to alter normal CBG function [83,84].
While certainly more comprehensive than their predecessors,
these models remain relatively coarse representations of the
interplay between the endocrine and immune systems.
This is particularly true of immune model granularity, especially
when one considers the complex signaling network supported by
immune cells as well as other immune-sensitive cells [85]. The
important role of key neurotransmitters linking the central nervous
system with the HPA axis and the immune system was also under-
represented in this first generation of models. For example,
norepinephrine and epinephrine stimulate the b2-adrenoreceptor-
cAMP-protein kinase A pathway inhibiting the production of
Th1/proinflammatory cytokines and stimulating the production of
Th2/anti-inflammatory cytokines causing a selective shift from
cellular to humoral immunity [86,87]. Additionally, lymphocytes
express most of the cholinergic components found in the nervous
system. Lymphocytes may be stimulated by, or release, acetylcho-
line thus constituting an immune regulating cholinergic system
secondary to the nervous system [88]. Another neurotransmitter,
neuropeptide Y (NPY), also serves as a powerful immune
modulator [89] and has recently been shown to play a role in
CFS [90]. These components are without question important,
however based on our initial observations from this piecewise
analysis we expect that increased detail will lead to the emergence
of additional response programs rather than the elimination of
attractors found here.
As these models are based on currently documented knowledge
of human physiology and regulatory biochemistry they are
necessarily incomplete. Nonetheless the simple models presented
here illustrate the importance of an integrative approach to
understanding complex illnesses. Further refinement of the model
to include more detailed description of interactions within and
between the HPA, HPG and immune systems could extend its
applicability to other illnesses as would the incorporation of other
key systems such as the brain and central nervous systems. Yet,
even with the coarse-grained co-regulation networks investigated
we found numerous stable resting states that differ significantly
from normal and were indicative of complex and persistent
regulatory imbalances. Findings such as this support the use of an
alternate model for disease, one which is not necessarily associated
with failure of individual components, but rather with a shift in
their coordinated actions away from normal regulatory behavior.
Response to exercise and other stressors has the potential to be
very different in these new regulatory regimes. This is something
that we have observed firsthand in our work with human GWI and
CFS subjects [91].
Finally, when considering alignment with the experimental data
presented here for CFS and GWI, it is important to remember
that it was never our hypothesis that these illnesses resulted solely
from the actions of homeostatic drive. Instead we proposed that
homeostatic drive might be a significant contributor to the
persistence of illness mechanisms. Because these naturally occur-
ring regimes, once instantiated, provide an alternate stable
homeostasis resistant to change, it may offer fertile ground in
support of many chronic pathological processes. The alignment of
several immune and endocrine markers modeled here with
experimental data from CFS and GWI, two chronic conditions,
would support at least partial involvement of the body’s own
homeostatic drive in facilitating the perpetuation of these
conditions. Correlation between these illness conditions and
predicted stable states does not imply causation. These results do
not suggest that homeostatic drive is the root cause of GWI or
CFS, only that it might serve to sustain these chronic illnesses. This
may promote resistance to therapy and the natural regulatory
barrier to change, even positive change, should at least be
considered in the design of robust treatment avenues. Knowledge
of the basins of attraction identified by the modeling methods
presented here can provide a comprehensive overview of
multisystem dysregulation. This knowledge may be used to
identify multiple therapeutic targets to be treated in conjunction
to correct overall system imbalance. This opens the possibility of
discrete interventions targeting multiple systems where treatment
could eventually be discontinued, leaving normal regulatory drive
to return the system to the correct resting state. This is very
different from conventional long-term administration of a drug
regimen, whereby the system is held artificially in a more
desirable, but unstable state through continued intervention.
Homeostatic Drive and Complex Chronic Illness
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